NovaBridge Biosciences American Depositary Shares (NBP)
Stock · NASDAQ · Health Care
$1.27as of 10/16/2026
Price chart
Active signals
NBP Signal Track Record
How signals performed across all stocks →What NBP's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 43 | -10.9% | 37% | September 23, 2026 |
| Bollinger Band Breakdown | 24 | -1.8% | 38% | September 25, 2026 |
| Bollinger Band Breakout | 14 | -6.8% | 36% | August 14, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -9.1% | 25% | February 5, 2026 |
| Any 20-session window (baseline) | -5.9% | 34% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NBP
NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 30
- Website
- www.novabridge.com/
Fundamentals
- 1-day range
- $1.29$1.32
- Market cap
- $196.15M
- P/E (trailing)
- —
- P/E (forward)
- -1.22
- EPS (trailing)
- $-0.19
- Dividend yield
- —
- Beta
- 1.69
- Avg. volume
- 388.0K
Forecasts
2 analyst ratings
NovaBridge Biosciences American Depositary Shares Competitors
Chosen by industry and closest market cap.
- NBPNovaBridge Biosciences American Depositary Shares$1.26▼ 2.33%Market cap $196.15MP/E —$1.26$6.79
- IMUXImmunic Inc. Common Stock$6.97▼ 1.83%Market cap $198.06MP/E —$5.06$17.43
- TNXPTonix Pharmaceuticals Holding Corp. Common Stock$6.04▼ 5.92%Market cap $185.71MP/E —$6.01$20.69
- NERVMinerva Neurosciences Inc Common Stock$2.35▼ 2.89%Market cap $206.85MP/E —$2.31$12.46
- GLSIGreenwich LifeSciences Inc. Common Stock$14.55▼ 5.03%Market cap $209.02MP/E —$7.78$34.1
- MSLESatellos Bioscience Inc. Common Stock$6.46▼ 5.56%Market cap $209.77MP/E —$7.56$18.98
- LFCRLifecore Biomedical Inc. Common Stock$6.38▼ 0.93%Market cap $181.55MP/E —$3.63$8.98
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NBP NovaBridge Biosciences American Depositary Shares | $196.15M | — | $1.26 | ▼ 2.33% | $1.26$6.79 |
| IMUX Immunic Inc. Common Stock | $198.06M | — | $6.97 | ▼ 1.83% | $5.06$17.43 |
| TNXP Tonix Pharmaceuticals Holding Corp. Common Stock | $185.71M | — | $6.04 | ▼ 5.92% | $6.01$20.69 |
| NERV Minerva Neurosciences Inc Common Stock | $206.85M | — | $2.35 | ▼ 2.89% | $2.31$12.46 |
| GLSI Greenwich LifeSciences Inc. Common Stock | $209.02M | — | $14.55 | ▼ 5.03% | $7.78$34.1 |
| MSLE Satellos Bioscience Inc. Common Stock | $209.77M | — | $6.46 | ▼ 5.56% | $7.56$18.98 |
| LFCR Lifecore Biomedical Inc. Common Stock | $181.55M | — | $6.38 | ▼ 0.93% | $3.63$8.98 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- NovaBridge’s Visara Plans To Develop HT006.2.2 As VIS-102, Second Clinical-Stage Program, Expanding Its Ophthalmology Portfolio Beyond Retinal Vascular Disease Into Ocular Surface Diseasebenzinga · 10/13/2026
- NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026Yahoo · 10/8/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/21/2026
- NovaBridge Biosciences H1 2026 Earnings Call: Complete TranscriptBenzinga · 9/18/2026
Insider Activity
Insider Actions →- Phillip Andrew Dennis · September 18, 2026 · Sale8.2K @ $0.71
- Phillip Andrew Dennis · September 17, 2026 · Option Exercise10.3K
- Phillip Andrew Dennis · September 17, 2026 · Option Exercise23.7K
- Sean Wuxiong Cao · September 9, 2026 · Sale108.0K @ $0.74
- Sean Wuxiong Cao · September 3, 2026 · Option Exercise45.3K
- Sean Wuxiong Cao · September 3, 2026 · Option Exercise102.2K
- Sean Wuxiong Cao · September 3, 2026 · Option Exercise104.2K
- Sean Wuxiong Cao · September 3, 2026 · Option Exercise235.1K
- Cong Claire Xu · August 31, 2026 · Sale3.3K @ $0.79
- Cong Claire Xu · August 30, 2026 · Option Exercise4.1K
- Cong Claire Xu · August 30, 2026 · Option Exercise9.4K
- Robert A. Lenz · August 22, 2026 · Option Exercise7.5K
- Robert A. Lenz · August 22, 2026 · Option Exercise17.2K
- Lin Liwei Lorraine · July 8, 2026 · Grant254.8K
- Mark Arnold Hagler · July 8, 2026 · Grant949.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 29.28M
- Total value held
- $71.73M
- Institutional holders
- 48
- Unknown6.03M
- Unknown5.98M
- Unknown3.84M
- Unknown3.00M
- Unknown2.26M
- Unknown1.39M
- Unknown1.13M
- Unknown1.00M
- Unknown700.0K
- Unknown627.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
NBP Included in List of Moving Health Care Stocks
NovaBridge Biosciences was highlighted in a report on health care stocks moving in Monday's after-market session. The stock is currently trading near its 52-week low, with recent technical signals indicating a breakdown and high volatility. This inclusion suggests increased market attention to the company's recent price action.
NBP Included in List of Moving Health Care Stocks. NovaBridge Biosciences was highlighted in a report on health care stocks moving in Monday's after-market session. The stock is currently trading near its 52-week low, with recent technical signals indicating a breakdown and high volatility. This inclusion suggests increased market attention to the company's recent price action.